Market research
5P8.F Five Prime Therapeutics, Inc
F EUR Financial Services
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 254M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 0.54
Community
Investor discussion
1 comment
Sign in to join the 5P8.F discussion.
5 years, 5 months ago
Five Prime Therapeutics, Inc is currently in a long term uptrend where the price is trading 100.9% above its 200 day moving average.
From a valuation standpoint, the stock is 92.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 105.5.
Five Prime Therapeutics, Inc's total revenue sank by 122.1% to $-708K since the same quarter in the previous year.
Its net income has increased by 33.5% to $-21M since the same quarter in the previous year.
Finally, its free cash flow grew by 55.5% to $-13M since the same quarter in the previous year.
Based on the above factors, Five Prime Therapeutics, Inc gets an overall score of 4/5.